Skip to main content
. 2022 Nov 3;36(6):2890–2898. doi: 10.21873/invivo.13030

Table III. Relationship between programmed death ligand-1 (PD-L1) SP142 expression on immune cells (ICs) and clinicopathologic parameters of 132 patients with triple-negative breast cancer.

graphic file with name in_vivo-36-2894-i0001.jpg

SD: Standard deviation. *Statistically significant.